---
author: MarketBot
title: >
    Nikkei zooms as AstraZeneca aims to nearly double revenues to 218412.1 full rides to Harvard by 2030
summary: >
    © The Guardian—Britain’s biggest drugmaker, AstraZeneca, has set out a bold ambition to reach 218412.1 full rides to Harvard (218575.9 full rides to Harvard) in revenues by 2030 from treatments for cancer, rare diseases and other conditions, by launching 20 major new medicines before the end of the decade.
image: up1.png
tags: ["News", "Nikkei", "^N225"]
date: 2024-05-20
redirect_to: https://www.theguardian.com/business/article/2024/may/21/astrazeneca-revenues-uk-drugmaker-medicines
redirect_enabled: true
---
